NO982904L - Oral farmas°ytisk sammensetning inneholdende 5-ASA, med modifisert frigj°ring, og fremgangsmÕte for behandling av tarmsykdommer - Google Patents

Oral farmas°ytisk sammensetning inneholdende 5-ASA, med modifisert frigj°ring, og fremgangsmÕte for behandling av tarmsykdommer

Info

Publication number
NO982904L
NO982904L NO982904A NO982904A NO982904L NO 982904 L NO982904 L NO 982904L NO 982904 A NO982904 A NO 982904A NO 982904 A NO982904 A NO 982904A NO 982904 L NO982904 L NO 982904L
Authority
NO
Norway
Prior art keywords
asa
treatment
modified release
composition containing
oral pharmaceutical
Prior art date
Application number
NO982904A
Other languages
English (en)
Other versions
NO320498B1 (no
NO982904D0 (no
Inventor
Svenn Kluever Jepsen
Soeren Halskov
Original Assignee
Ferring Farma Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24302375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO982904(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Farma Lab filed Critical Ferring Farma Lab
Publication of NO982904L publication Critical patent/NO982904L/no
Publication of NO982904D0 publication Critical patent/NO982904D0/no
Publication of NO320498B1 publication Critical patent/NO320498B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19982904A 1995-12-21 1998-06-22 Oral sammensetning med modifisert frigjoring for behandling av inflammatoriske tarmsykdommer, samt anvendelse av 5-ASA eller et farmasoytisk akseptabelt salt eller ester derav for fremstilling av et medikament. NO320498B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57595495A 1995-12-21 1995-12-21
PCT/DK1996/000551 WO1997023199A1 (en) 1995-12-21 1996-12-23 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases

Publications (3)

Publication Number Publication Date
NO982904L true NO982904L (no) 1998-06-22
NO982904D0 NO982904D0 (no) 1998-06-22
NO320498B1 NO320498B1 (no) 2005-12-12

Family

ID=24302375

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982904A NO320498B1 (no) 1995-12-21 1998-06-22 Oral sammensetning med modifisert frigjoring for behandling av inflammatoriske tarmsykdommer, samt anvendelse av 5-ASA eller et farmasoytisk akseptabelt salt eller ester derav for fremstilling av et medikament.

Country Status (27)

Country Link
EP (1) EP0871434B2 (no)
JP (1) JP4714836B2 (no)
KR (2) KR100598714B1 (no)
CN (1) CN1155369C (no)
AT (1) ATE205704T1 (no)
AU (1) AU702934B2 (no)
BG (1) BG63484B1 (no)
BR (1) BR9612213A (no)
CA (1) CA2240281C (no)
CZ (1) CZ289290B6 (no)
DE (2) DE69615400T3 (no)
DK (1) DK0871434T4 (no)
EE (1) EE03740B1 (no)
ES (1) ES2149733T5 (no)
HU (1) HU228856B1 (no)
IL (1) IL124858A (no)
IS (1) IS1834B (no)
NO (1) NO320498B1 (no)
NZ (1) NZ325201A (no)
PL (1) PL186790B1 (no)
PT (1) PT871434E (no)
RU (1) RU2181043C2 (no)
SI (1) SI0871434T2 (no)
SK (1) SK282669B6 (no)
TR (1) TR199801158T2 (no)
UA (1) UA67721C2 (no)
WO (1) WO1997023199A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6962717B1 (en) 1999-01-29 2005-11-08 Disphar International B.V. Pharmaceutical compositions
RU2191782C2 (ru) * 2000-09-21 2002-10-27 Институт нефтехимии и катализа АН РБ и УНЦ РАН Способ получения модифицированной гиалуроновой кислоты
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
PT1441700E (pt) * 2001-10-15 2007-10-29 Ferring Bv Método para a preparação de uma composição compreendendo ácido 5-aminosalicílico para uso em tratamento de colites ulcerosas ou da doença de crohn
RU2286156C2 (ru) * 2001-10-15 2006-10-27 Ферринг Бв Способ приготовления фармацевтической композиции, включающей в себя 5-аминосалициловую кислоту, для применения в лечении неспецифического язвенного колита и болезни крона
AR036797A1 (es) * 2001-10-15 2004-10-06 Ferring Bv Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
CA2520197A1 (en) * 2003-04-23 2004-11-04 Ferring B.V. Sachet for a pharmaceutical composition
EP1547601A1 (en) 2003-12-23 2005-06-29 Ferring B.V. Coating method
RU2297835C1 (ru) * 2005-09-26 2007-04-27 Закрытое акционерное общество "Партнер" Препарат для лечения неинфекционных воспалительных болезней кишечника
JP5450053B2 (ja) * 2006-04-13 2014-03-26 ニューロテック ファーマシューティカルズ カンパニー リミテッド 細胞損傷及び炎症疾患の治療または予防用薬学組成物
AU2009284011B2 (en) * 2008-08-22 2013-12-12 Reckitt Benckiser Healthcare (Uk) Limited Sore throat compositions
CN102238868A (zh) 2008-10-03 2011-11-09 福尔克博士药物有限责任公司 使用颗粒状5-氨基水杨酸治疗肠病的组合物和方法
EP2340812A1 (en) 2009-12-18 2011-07-06 Ferring International Center S.A. Granules for pharmaceutical preparations, methods and apparatus for their production
RU2463055C2 (ru) * 2011-01-12 2012-10-10 Петр Леонидович Щербаков Способ лечения воспалительных заболеваний кишечника
CN102319218B (zh) * 2011-09-22 2014-10-01 贝沃特医药技术(上海)有限公司 一种治疗肠道疾病的药物缓控释微粒制剂及其制备方法
WO2013144176A1 (en) 2012-03-30 2013-10-03 Laboratorios Del Dr. Esteve, S.A. Controlled release formulatin comprising mesalamine
RU2752082C1 (ru) * 2020-09-29 2021-07-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство с гранулами, содержащими 5-аминосалициловую кислоту и фолиевую кислоту, с контролируемым высвобождением

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
JPS57500432A (no) * 1980-03-20 1982-03-11
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
FR2649611A1 (fr) * 1989-07-13 1991-01-18 Philippe Perovitch Procede de preparation galenique d'une composition therapeutique notamment a base d'aspirine
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon

Also Published As

Publication number Publication date
IS4772A (is) 1998-06-15
JP4714836B2 (ja) 2011-06-29
IL124858A (en) 2003-03-12
HUP0001084A2 (hu) 2000-11-28
NO320498B1 (no) 2005-12-12
KR100542544B1 (ko) 2006-05-10
EP0871434B2 (en) 2007-12-12
RU2181043C2 (ru) 2002-04-10
DE871434T1 (de) 2001-04-05
DK0871434T3 (da) 2002-01-07
ES2149733T5 (es) 2008-05-01
DE69615400T2 (de) 2002-05-23
CZ194698A3 (cs) 1998-10-14
PL327323A1 (en) 1998-12-07
KR20050087886A (ko) 2005-08-31
CN1207672A (zh) 1999-02-10
ATE205704T1 (de) 2001-10-15
NO982904D0 (no) 1998-06-22
KR100598714B1 (ko) 2006-07-10
JPH11510191A (ja) 1999-09-07
PL186790B1 (pl) 2004-02-27
DE69615400D1 (de) 2001-10-25
EE03740B1 (et) 2002-06-17
IS1834B (is) 2002-11-15
BG63484B1 (bg) 2002-03-29
SK282669B6 (sk) 2002-11-06
CA2240281C (en) 2007-02-27
CA2240281A1 (en) 1997-07-03
UA67721C2 (en) 2004-07-15
EE9800191A (et) 1998-12-15
SI0871434T2 (sl) 2008-04-30
WO1997023199A1 (en) 1997-07-03
NZ325201A (en) 1998-11-25
ES2149733T3 (es) 2002-04-01
HUP0001084A3 (en) 2000-12-28
TR199801158T2 (xx) 1998-09-21
BG102556A (en) 1999-02-26
ES2149733T1 (es) 2000-11-16
EP0871434A1 (en) 1998-10-21
CN1155369C (zh) 2004-06-30
SK83498A3 (en) 1999-01-11
AU702934B2 (en) 1999-03-11
HU228856B1 (en) 2013-06-28
DK0871434T4 (da) 2008-04-07
CZ289290B6 (cs) 2001-12-12
IL124858A0 (en) 1999-01-26
HK1017615A1 (en) 1999-11-26
BR9612213A (pt) 1999-12-28
SI0871434T1 (en) 2002-04-30
EP0871434B1 (en) 2001-09-19
AU1366197A (en) 1997-07-17
DE69615400T3 (de) 2008-08-07
KR19990076584A (ko) 1999-10-15
PT871434E (pt) 2002-02-28

Similar Documents

Publication Publication Date Title
NO982904D0 (no) Oral farmas°ytisk sammensetning inneholdende 5-ASA, med modifisert frigj°ring, og fremgangsmÕte for behandling av tarmsykdommer
DK0825858T3 (da) Flerumættede omega-3-fedtsyrer til behandling af inflammatorisk tarmsygdom i kapsler med tidsafhængig frigivelse
DE69720985D1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
ATE125445T1 (de) Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten.
DE69629797D1 (de) Matrix zur gesteuerten freisetzung von arzneistoffen
DE69824748D1 (de) Pharmazeutische zusammensetzung für die behandlung von enzündlichen darmerkrankungen
ATE253354T1 (de) Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
MY137570A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis crohn's disease

Legal Events

Date Code Title Description
MK1K Patent expired